Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Nintedanib in Progressive Pneumoconiosis Study (NiPPS): a Collaborative NSW Treatment Trial

NCT04161014 is registered in ClinicalTrials.gov with Holdsworth House Medical Practice as lead sponsor.

NCT NCT04161014
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04161014 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Nintedanib in Progressive Pneumoconiosis Study (NiPPS): a Collaborative NSW Treatment Trial
Lead sponsor
Holdsworth House Medical Practice
Phase
Phase 2
Overall status
Unknown status
Start date
October 9, 2020
Completion date
February 28, 2025
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asbestosis, pneumoconiosis coal, silicosis